By Kim Tzoumakas, CEO, VytlOne
Overview
Health system pharmacy is one of the few growth levers a nonprofit or safety-net hospital fully controls, no new service line, payer negotiation, or certificate of need required. The opportunity is capture: using AI to give finance and pharmacy the same real-time visibility, so a hospital claims the full 340B savings it is already entitled to and turns them into mission capital. Most systems leave meaningful savings unclaimed, not through negligence, but because the rules have outgrown manual processes.
Pharmacy’s role
Ask most health system CEOs what their pharmacy does for the organization, and you’ll get some version of the same answer: it fills prescriptions, it manages inventory, it’s a cost center you keep an eye on. That answer is out of date. Health system pharmacies are one of the few growth levers a nonprofit or safety-net hospital fully controls. No new service line, no payer negotiation, no certificate of need required. Just the discipline to capture what you’re already entitled to under a program designed to support your mission.
It’s worth saying plainly: Congress created 340B so hospitals serving vulnerable communities could turn drug pricing into mission capital rather than having it all retained by manufacturers. That’s not a loophole and it’s not a gray area. It’s the design. When a hospital captures its full 340B savings, it’s using the program exactly as intended: funding charity care, keeping community clinics open, reinvesting in the services that make the mission possible. The systems doing this well aren’t taking advantage of the program. They’re doing their job.
The real story isn’t entitlement, it’s capture
In hundreds of gap analyses, we’ve found meaningful uncaptured 340B savings in nearly every hospital we have partnered with to support pharmacy optimization. That is not because anyone dropped the ball. It’s because eligibility screening, manufacturer restrictions, contract pharmacy rules, and split billing have gotten more complex than manual processes were ever built to handle.
Specialty pharmacy is where the gap runs deepest. Oncology, rare disease, and transplant patients are exactly the ones most likely to slip through manual screening, and a well-run specialty program at a 340B hospital can generate several times the revenue per prescription of a retail program.
Why the 2027 rebate model change raises the stakes
The 340B rebate model change scheduled to take effect on January 1, 2027 is arguably the most consequential shift to hit nonprofit pharmacy economics since the Affordable Care Act. In a lot of systems, the pharmacy leaders and the CFO still haven’t sat down to talk through what it means for their margin or how to monitor the manufacturers and support their pharmacy teams who are already overworked. This is an expensive impending impact with significant complexity and manufacturers who are motivated to pay less to leave unaddressed. Hospital groups including the American Hospital Association have raised concerns about the model’s cash-flow and administrative burden on covered entities.
The chief pharmacy officer sees the gap first
Chief pharmacy officers are usually the first ones to sense the gap. They just don’t always have the data, the platform, or the resources to prove the size of it and make the case for investment. The CPOs who are getting in front of this become some of the most valuable strategic partners a CEO and CFO have, protecting the integrity of the program and keeping the dollars associated with it inside the system. The best-run 340B programs I’ve seen have one thing in common: the CEO, the CFO, and the pharmacy leaders are looking at the same numbers, in the same room. That alignment is rarer than it should be, and when it happens, the results aren’t incremental.
How AI closes the gap between finance and pharmacy
This is the gap VytlAIQ was built to close, giving finance and pharmacy the same real-time visibility so they’re planning from shared facts instead of competing hunches. It doesn’t replace the pharmacy team. In fact, the team is critical to its success. It gives them the speed and evidence to stay ahead of a program that keeps getting more complex, not less.
The question worth asking
Your pharmacy program is either generating margin that funds your mission, or it’s quietly limiting it. There’s not much of a middle ground. I can usually tell a health system leader, within a conversation, roughly what their pharmacy should be capturing versus what it likely is, and that gap tends to open up a more hopeful conversation than people expect, because it’s not a problem you have to solve by cutting something. It’s capital you’re already entitled to and simply haven’t claimed yet. The 2027 rebate model puts even the best-optimized systems at risk of losing significant dollars, or at a minimum, facing significant delays in payment.
The systems that lean into this now, pharmacy and finance in the same room looking at the same data, are the ones that will have room to grow when everyone else is still debating whether the opportunity or the risk is real. If you want to see what that looks like in practice, talk with our team.
Key takeaways
- Health system pharmacy is one of the few growth levers a hospital fully controls, and 340B savings are mission capital it is already entitled to.
- Most systems leave meaningful savings unclaimed because eligibility, manufacturer restrictions, and split billing have outgrown manual processes, with specialty pharmacy the deepest gap.
- The January 2027 rebate model change raises the stakes for nonprofit pharmacy economics.
- AI closes the gap by giving finance and pharmacy the same real-time visibility, so they plan from shared facts. It supports the pharmacy team, it does not replace it.
Frequently asked questions
Why should a hospital treat pharmacy as a strategic asset?
Because it is one of the few growth levers a nonprofit or safety-net hospital fully controls. Capturing the full 340B savings a hospital is entitled to requires no new service line, payer negotiation, or certificate of need. Those savings become mission capital that funds charity care, community clinics, and the services that make the mission possible.
What is 340B mission capital?
It is the savings a hospital captures under the 340B program, used as Congress intended: to fund care for vulnerable communities. When a hospital captures its full 340B savings, it is using the program exactly as designed, turning drug pricing into support for its mission rather than leaving that value with manufacturers.
How does AI help a health system capture more 340B value?
AI gives finance and pharmacy the same real-time visibility, so they plan from shared facts instead of competing estimates. It helps teams keep pace with eligibility screening, manufacturer restrictions, contract pharmacy rules, and split billing that have grown too complex for manual processes. It supports the pharmacy team rather than replacing it.
How does the 2027 rebate model change affect nonprofit hospitals?
The 340B rebate model change taking effect in January 2027 is a significant shift for nonprofit pharmacy economics. It puts even well-optimized systems at risk of losing dollars or facing payment delays, which is why finance and pharmacy leaders should align on their exposure now rather than after it takes effect.